Challenges to the Economic Evaluation of New Biotechnological Interventions in Healthcare James Mason Current Opinion 22 September 2012 Pages: 119 - 125
A Review of Quality-of-Life Evaluations in Prostate Cancer Sunshine D. SommersScott D. Ramsey Review Article 22 September 2012 Pages: 127 - 140
Review of Quality-of-Life Evaluations in Patients with Angina Pectoris Afschin GandjourKarl W. Lauterbach Review Article 22 September 2012 Pages: 141 - 152
Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis Andrea MessoriSabrina TrippoliGaetano Zaccara Original Research Article 22 September 2012 Pages: 153 - 163
Estimating Long Term Cost Savings from Treatment of Alzheimer’s Disease Paul FennAlastair Gray Original Research Article 22 September 2012 Pages: 165 - 174
The Influence of Hospital-Based Prescribers on Prescribing in General Practice John FeelyRobert ChanBrendan O’Shea Original Research Article 22 September 2012 Pages: 175 - 181
Cost Comparison of Antibacterial Therapies for Serious Infections Guy ScottHelen M. ScottPhilippa Cotterell Original Research Article 22 September 2012 Pages: 183 - 192
Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy Stephen MorrisEd Godber Original Research Article 22 September 2012 Pages: 193 - 205